Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
April 16, 2024
0
Date of Patent
October 29, 2024
0
Patent Application Number
18637283
0
Patent Citations
‌
US Patent 9896478 Antibody purification by cation exchange chromatography
0
‌
US Patent 9968676 Subcutaneous anti-HER2 antibody formulations and uses thereof
0
‌
US Patent 9969811 Pertuzumab variants and evaluation thereof
0
‌
US Patent 10160811 Treatment with anti-ErbB2 antibodies
0
‌
US Patent 10280228 Treatment with anti-ErbB2 antibodies
0
‌
US Patent 10385405 Gene expression markers of tumor resistance to HER2 inhibitor treatment
0
‌
US Patent 10501491 Protein purification
0
‌
US Patent 10689457 Treatment of metastatic breast cancer
0
‌
US Patent 10849849 Subcutaneous HER2 antibody formulations
0
‌
US Patent 10898570 Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor
0
•••
Patent Inventor Names
Mark C. Benyunes
0
Graham Alexander Ross
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12128103
0
Patent Primary Examiner
‌
Hong Sang
0
CPC Code
‌
A61K 2039/507
0
‌
A61K 2039/545
0
‌
A61K 2039/55
0
‌
A61K 31/337
0
‌
A61K 39/39558
0
‌
A61K 9/009
0
‌
C07K 16/32
0
‌
A61P 35/00
0
‌
A61K 39/3955
0
‌
A61K 31/704
0

Find more entities like US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.